Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 21, 2012Journal of Obstetrics and Gynaecology

The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy

View Full Paper
Ask AI
Bookmark
Share

Authors

JHJ.R. HutsonJMJeremy N. MatlowUniversity of TorontoMMMyla E. MorettiHealth Canada

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hutson et al. (2012) studied this question.

synapsesocial.com/papers/6aade3ad54e9ccae2eb8ab53https://doi.org/10.3109/01443615.2012.716106
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study2010 · 180 citations
  2. 2Birth defects after maternal exposure to corticosteroids: Prospective cohort study and meta-analysis of epidemiological studies2000 · 957 citations
  3. 3Ulcerative colitis in pregnancy in Israel1981 · 38 citations
  4. 46-Mercaptopurine in the Management of Inflammatory Bowel Disease: Short- and Long-Term Toxicity1989 · 737 citations
  5. 5Pregnancy and IBD treatment: This challenging interplay from a patients' perspective2009 · 90 citations